What is the enterprise number of Orexys?

The enterprise number of Orexys is BE1017082018.

What is the address of Orexys?

The registered office of Orexys is located at Motstraat 72/8, 2800 Mechelen.

When was Orexys founded?

Orexys was founded on 7 December 2024.

Does Orexys have a website?

No website is currently known for Orexys.

How much profit did Orexys make in 2025?

Orexys posted a profit after taxes of € 186,885 in financial year 2025.

What is the revenue of Orexys?

As a small company, Orexys is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 126,746.

Where can I find the annual accounts of Orexys?

Orexys files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.

Who are the directors of Orexys?

According to the 2025 annual accounts, the directors of Orexys are: Quentin Speeckaert, James Dehé.

Orexys (Private Limited) - Mechelen (2800) - BE1017082018

Financials

Financial year 2025

Worth noting

Little cash and receivables against the short-term debts.

Gross margin

€ 126,746

Profit

Healthy

€ 186,885

Debts

High

€ 7.5 million

Orexys from Mechelen, company number BE1017082018, closed financial year 2025 with a result of € 186,885 after tax. For that financial year Orexys recorded a gross margin of € 126,746 and equity of € 188,885. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 29, 2026.

What happened at Orexys?

What happened at Orexys in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 29, 2026 New annual accounts for financial year 2025: profit of € 186,885. Source: NBB ↗
Dec 7, 2024 New establishment in Mechelen. KBO
2024 Quentin Speeckaert became a director. NBB
2024 James Dehé became a director. NBB
Dec 7, 2024 Start of the company according to the CBE. KBO

Original PDFs at the National Bank ↗

A new publication or filing at Orexys? We notify you, reason included.

Follow Orexys

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New

Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Quentin Speeckaert

James Dehé

Orexys

IMMUNO-CELL 85%

Behind Orexys are Quentin Speeckaert and James Dehé. It owns 85% of IMMUNO-CELL itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Quentin Speeckaert

Director

Also active at: IMMUNO-CELL INTERNATIONAL, EXETERA

since 2024

James Dehé

Director

since 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Motstraat 72/8

2800 Mechelen

2.372.146.876

Motstraat 72 box 8

2800 Mechelen

Active since 7 December 2024

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 1017.082.018
VAT number: BE 1017.082.018
Registered office: Motstraat 72/8, 2800 Mechelen
Names & denominations: Orexys
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 7 December 2024
Peppol: Active · Active since 17 Aug 2026

View on CBE Public ↗ Annual accounts (NBB) ↗